The Robotic Surgeon Blog
-
Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial.
INTERPRETATION: 6 months of neoadjuvant androgen deprivation combined radiotherapy is an effective treatment option for locally advanced prostate cancer, particularly in men without nodal metastases or pre-existing metabolic comorbidities that could be exacerbated by prolonged androgen deprivation. via Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01…
-
Statins make radiation more effective at curing prostate cancer, study suggests
Statins Make Radiation More Effective at Curing Prostate Cancer, Study Suggests ScienceDaily (Mar. 25, 2011) — Men with high-risk prostate cancer who take statin drugs commonly used to lower cholesterol while receiving radiation therapy are less likely to have their cancer return than patients who do not take these medications, according to a study published…
-
-
Better patient counseling needed on post-RP erectile function – – UrologyTimes
Acting on anecdotal evidence, Dr. Nelson and his co-authors, Peter Scardino, MD, and John P. Mulhall, MD, assessed the erectile function of 250 men average age, 59±8 years pre- and post-radical prostatectomy. Of the men with baseline erectile function scores ≥24 mild to no dysfunction, about one-third 32% regained function; however, well over half 60%…
-
Added Radiation to ADT May Improve Survival – Renal and Urology News
Men with locally advanced prostate cancer (PCa) have a better chance of survival when they add radiation therapy (RT) to their hormone therapy, according to research presented at the 52nd annual meeting of the American Society for Radiation Oncology. via Added Radiation to ADT May Improve Survival – Renal and Urology News. This is another…
-
Dutasteride Slows Prostate Cancer Progression – Renal and Urology News
ORLANDO—Dutasteride, a drug widely prescribed for treating benign prostatic enlargement, lowers the risk of prostate cancer PCa progression in men undergoing active surveillance for the disease, researchers concluded. via Dutasteride Slows Prostate Cancer Progression – Renal and Urology News. Dutasteride has been used for BPH and is thought to help reduce the risk of developing…
-
MedWire News – Oncology – PCA3 predicts prostate tumor volume and could indicate AS suitability
MedWire News: Prostate cancer patients urinary prostate cancer antigen 3 PCA3 scores are strongly indicative of tumor volume, and could be a useful marker of suitability for treatment with active surveillance AS, study findings show. via MedWire News – Oncology – PCA3 predicts prostate tumor volume and could indicate AS suitability. I have been using…
-
FDA committee votes down 5-ARIs for prostate cancer risk reduction – – UrologyTimes
“Although the REDUCE trial demonstrated a risk reduction in a large number of men, the committee chose to focus on a small number of high-grade cancers and determined that this class of drugs is inappropriate for prostate cancer risk reduction, even in the population of men with elevated PSA and previous negative biopsy,” added Dr.…
-
Robotic prostate surgery: a health care conundrum
Patients in Vancouver will be asked to pay a fee if they opt for robotic surgery for prostate cancer over conventional surgery. This is an important change in the way healthcare is usually paid for in Canada.